X-trodes

Company Overview

Snapshot

Founded in July 2019 by Ziv Peremen and Prof. Yael Hanein, X-trodes operates with 11–50 employees. The company has raised $11.92 million across 3 funding rounds from 4 investors. In June 2023, X-trodes was awarded funding from the European Innovation Council (EIC) to advance its home sleep monitoring solution.

Business overview

X-trodes is a biotechnology company focused on remote physiological monitoring for clinical, home, and extreme environments. The company's core technology is a wireless, flexible, ultra-soft dry multi-electrode patch array system that measures and analyzes electrophysiological signals (EEG, EMG, EOG, ECG). This platform integrates innovative flexible sensors, a miniaturized low-noise Bluetooth amplifier, and cloud-based analytics driven by advanced algorithmic methodologies. X-trodes serves markets including medical and wellness monitoring, as well as high-stakes environments like aviation and defense with products such as PilotSense for pilot safety and HM-NEX for hands-free system control. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Devices, with applications extending to Aerospace, Defense & HLS.

Strategic signal

In June 2023, X-trodes secured significant funding from the European Innovation Council (EIC) to advance its home sleep monitoring solution. This award validates the company's innovative approach to non-invasive physiological monitoring and signals strong European institutional backing for its technology, positioning X-trodes for accelerated development and market penetration in the digital health sector.

Company Intelligence Q&A

What significant funding did X-trodes receive in June 2023?

In June 2023, X-trodes was awarded funding from the European Innovation Council (EIC) to advance its breakthrough home sleep monitoring solution.

When was X-trodes founded and by whom?

X-trodes was founded in July 2019 by Ziv Peremen and Prof. Yael Hanein.

What is X-trodes' primary focus in biotechnology?

X-trodes specializes in remote physiological monitoring across clinical, home, and extreme environments, utilizing a wireless, flexible multi-electrode patch array system.

Which investors participated in X-trodes' funding round in December 2020?

In December 2020, X-trodes received funding from The Chartered Group and Welltech Ventures.

What is the total capital raised by X-trodes?

X-trodes has raised a total of $11.92 million across 3 funding rounds.